In atopic dermatitis trial, abrocitinib offers faster itch relief than dupilumab October 7, 2021Atopic Dermatitis
Lessons from an ethnic skin center: Awareness and respect for diversityOctober 7, 2021Business of MedicineDiversity in MedicineAesthetic DermatologyContact Dermatitis
New York’s largest health care provider fires 1,400 unvaccinated employeesOctober 6, 2021COVID-19 Updates
JAK inhibitor provides impressive hair growth for patients with alopecia areataOctober 5, 2021Hair & Nails
Ruxolitinib cream meets primary endpoints in phase 3 vitiligo trialOctober 5, 2021Pigmentation Disorders
COVID-19: Two more cases of mucosal skin ulcers reported in male teensOctober 4, 2021COVID-19 UpdatesInfectious DiseasesPediatrics
Extension study finds dupilumab effective for up to 1 year in teens with ADOctober 4, 2021Atopic DermatitisPediatrics
Oteseconazole promising for recurrent yeast infectionsOctober 4, 2021Infectious DiseasesMedical Dermatology
